Reactivation of HCMV during RT of the brain results in critical illness and early mortality

Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, Dörfler A, Engelhorn T, Eyüpoglu IY, Putz F, Semrau S, Gaipl U, Fietkau R (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Radiotherapy and Oncology Elsevier

Publisher: ELSEVIER IRELAND LTD

City/Town: CLARE

Pages Range: S193-S194

Conference Proceedings Title: RADIOTHERAPY AND ONCOLOGY

DOI: 10.1016/s0167-8140(21)00385-6

Authors with CRIS profile

Benjamin Frey Department of Radiation Oncology Nicole Goerig Department of Radiation Oncology Ina Becker Department of Radiation Oncology Anna-Jasmina Donaubauer Department of Radiation Oncology Klaus Korn Institute of Clinical and Molecular Virology Klaus Überla Lehrstuhl für Klinische und Molekulare Virologie Manuel Schmidt Neuroradiologisches Institut Arnd Dörfler Department of Neuroradiology Tobias Martin Engelhorn Department of Neuroradiology Ilker Yasin Eyüpoglu Department of Neurosurgery Florian Putz Department of Radiation Oncology Sabine Semrau Medizinische Fakultät Udo Gaipl Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie

How to cite

APA:

Frey, B., Goerig, N., Becker, I., Donaubauer, A.-J., Korn, K., Überla, K.,... Fietkau, R. (2020). Reactivation of HCMV during RT of the brain results in critical illness and early mortality. In RADIOTHERAPY AND ONCOLOGY (pp. S193-S194). CLARE: ELSEVIER IRELAND LTD.

MLA:

Frey, Benjamin, et al. "Reactivation of HCMV during RT of the brain results in critical illness and early mortality." Proceedings of the RADIOTHERAPY AND ONCOLOGY CLARE: ELSEVIER IRELAND LTD, 2020. S193-S194.

BibTeX: Download